VCV001803784.1 - ClinVar

NM_005121.3(MED13):c.4802C>A (p.Ser1601Ter)

Germline

Classification

The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.

(1)

Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.

Likely pathogenic

criteria provided, single submitter

Somatic

No data submitted for somatic clinical impact

Somatic

No data submitted for oncogenicity

Variant Details

Identifiers

NM_005121.3(MED13):c.4802C>A (p.Ser1601Ter)

Variation ID: 1803784 Accession: VCV001803784.1

Type and length

single nucleotide variant, 1 bp

Location

Cytogenetic: 17q23.2 17: 61965048 (GRCh38) [ NCBI UCSC ] 17: 60042409 (GRCh37) [ NCBI UCSC ]

Timeline in ClinVar

	First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.	Last submission Help The date of the most recent submission for each type of classification for this variant.	Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline	Dec 17, 2022	Dec 17, 2022	May 5, 2020

HGVS

Nucleotide	Protein	Molecular consequence
NM_005121.3:c.4802C>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.	NP_005112.2:p.Ser1601Ter	nonsense
NC_000017.11:g.61965048G>T
NC_000017.10:g.60042409G>T
NG_046948.1:g.105264C>A

Protein change

S1601*

Other names

p.Ser1601Ter

Canonical SPDI

NC_000017.11:61965047:G:T

Functional consequence Help The effect of the variant on RNA or protein function, based on experimental evidence from submitters.

protein truncation; Variation Ontology [ VariO:0015]

Global minor allele frequency (GMAF) Help The global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.

Allele frequency Help The frequency of the allele represented by this VCV record.

Links

VarSome

Genes

Gene	OMIM	ClinGen Gene Dosage Sensitivity Curation		Variation Viewer Help Links to Variation Viewer, a genome browser to view variation data from NCBI databases.	Related variants
Gene	OMIM	HI score Help The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.	TS score Help The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.		Within gene Help The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants.	All Help The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene.
MED13		-	-	GRCh38 GRCh37	418	451

Conditions - Germline

Condition Help The condition for this variant-condition (RCV) record in ClinVar.	Classification Help The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions)	Review status Help The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status.	Last evaluated Help The most recent date that a submitter evaluated this variant for the condition.	Variation/condition record Help The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page.
Intellectual developmental disorder 61	Likely pathogenic (1)	criteria provided, single submitter	May 5, 2020	RCV002467480.1

Submissions - Germline

Classification Help The submitted germline classification for each SCV record. (Last evaluated)	Review status Help Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria)	Condition Help The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant.	Submitter Help The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar.	More information Help This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter.
Likely pathogenic (May 05, 2020)	criteria provided, single submitter (ACMG Guidelines, 2015) Method: research	Intellectual developmental disorder 61 (Autosomal dominant inheritance) Affected status: yes Allele origin: maternal	Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics Accession: SCV002762858.1 First in ClinVar: Dec 17, 2022 Last updated: Dec 17, 2022	Comment: A heterozygous nonsense variation in exon 20 of the MED13 gene that results in premature truncation of the Serine at codon 1601. The observed variant … (more) A heterozygous nonsense variation in exon 20 of the MED13 gene that results in premature truncation of the Serine at codon 1601. The observed variant c.4802C>A(p.Ser1601Ter) has not been reported in the 1000 genomes and gnomAD databases. The in silico prediction of the variant are damaging by DANN and MutationTaster2. The reference codon is conserved across species. Segregation analysis showed this variant to be inherited from an asymptomatic mother. In summary, the variant meets our criteria to be classified as a likely pathogenic variant. (less) Clinical Features: Impaired social interactions (present) , Poor eye contact (present) , Recurrent hand flapping (present) , Bruxism (present) , Autistic behavior (present) , Somatic sensory dysfunction … (more) Impaired social interactions (present) , Poor eye contact (present) , Recurrent hand flapping (present) , Bruxism (present) , Autistic behavior (present) , Somatic sensory dysfunction (present) , Motor stereotypy (present) , Delayed speech and language development (present) , Global developmental delay (present) (less) Age: 0-9 years Sex: male Ethnicity/Population group: ST Geographic origin: India Method: DNA was used to perform targeted gene capture using a custom capture kit. Libraries were sequenced to mean >80-100X coverage on Illumina sequencing platform. Sequence obtained were aligned to human references genome using BWA program and analyzed using Picard and GATK-Lite toolkit to identify variants in the targeted genes relevant to clinical indication.

Comment:

A heterozygous nonsense variation in exon 20 of the MED13 gene that results in premature truncation of the Serine at codon 1601. The observed variant c.4802C>A(p.Ser1601Ter) has not been reported in the 1000 genomes and gnomAD databases. The in silico prediction of the variant are damaging by DANN and MutationTaster2. The reference codon is conserved across species. Segregation analysis showed this variant to be inherited from an asymptomatic mother. In summary, the variant meets our criteria to be classified as a likely pathogenic variant.

Germline Functional Evidence

Functional Help The functional consequence of the variant, based on experimental evidence and provided by the submitter. consequence	Method Help A brief description of the method used to determine the functional consequence of the variant. A citation for the method is included, when provided by the submitter.	Result Help A brief description of the result of this method for this variant.	Submitter Help The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar.	More information Help This column includes more information supporting functional evidence for the germline classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter.
protein truncation (VariO:0015)	DNA was used to perform targeted gene capture using a custom capture kit. Libraries were sequenced to mean >80-100X coverage on Illumina sequencing platform. Sequence obtained were aligned to human references genome using BWA program and analyzed using Picard and GATK-Lite toolkit to identify variants in the targeted genes relevant to clinical indication.	Result not provided	Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics Accession: SCV002762858.1

Comment:

Citations for germline classification of this variant

There are no citations for germline classification of this variant in ClinVar. If you know of citations for this variation, please consider submitting that information to ClinVar.

Text-mined citations for this variant ...

Record last updated Dec 24, 2022

ClinVar Genomic variation as it relates to human health

NM_005121.3(MED13):c.4802C>A (p.Ser1601Ter)

Variant Details

Genes

Conditions - Germline

Submissions - Germline

Germline Functional Evidence

Citations for germline classification of this variant

Text-mined citations for this variant ...